Skip to main content
Caplight Logo









Newwave Biotech

Newwave Biotech

Private
AdelaideEnergy & Sustainabilityhttps://newwavebio.au/

Last Round

Accelerator

Aug 22, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Newwave Biotech is an agriculture technology company that provides biological agricultural formulations intended to improve soil health and crop productivity.

Sector

Energy & Sustainability

Verticals

Biotechnology, E-commerce

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

bio-fertilisersoil inoculantsbiostimulantsag biologicalssoil healthregenerative agriculturelive mycorrhizaeVesicular Arbuscular MycorrhizaeVAMTrichodermaagtechsustainable farmingbio-fungicideprecision biologicalscustom biological blends

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Newwave Biotech Comparables

Compare Newwave Biotech with similar companies based on industry and business-model similarity.

Newwave Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sinochem Holdings Corporation Ltd.
71%
Yara International
61%
Sound Agriculture
60%

Newwave Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 22, 2024

Key People

Founding team and executive leadership

Simon Humphrys

Chief Executive Officer

Executive Team

Newwave Biotech Investors

Notable investors and investment history

Newwave Biotech investors
InvestorRounds
Plug and Play TopekaAccelerator
SVG Ventures|THRIVEAccelerator
SenteAccelerator
Go TopekaAccelerator
Foxglove CapitalAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 54% MoM.

  • Mar 1, 2026

    Monthly visitors grew 938% MoM, from 139 to 1.4K.

Newwave Biotech Filings

Explore SEC and related filing metadata, where available.

Newwave Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Newwave Biotech's valuation, stock price, and market status.

Is Newwave Biotech a public or private company?

Newwave Biotech is a private company.

What is the current stock price of Newwave Biotech?

Newwave Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Newwave Biotech worth (valuation)?

Valuation information for Newwave Biotech is not publicly available.

Can I buy Newwave Biotech stock?

Newwave Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Newwave Biotech's last funding round?

Newwave Biotech's most recent funding round was Accelerator on August 22, 2024.

Who are the main investors in Newwave Biotech?

Key investors in Newwave Biotech include Plug and Play Topeka, SVG Ventures|THRIVE, Sente, Go Topeka, Foxglove Capital.

Will Newwave Biotech IPO soon?

No public IPO plans have been announced for Newwave Biotech.

How can I track Newwave Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Newwave Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAdelaide
Employee Range5
Year Founded2022
Last FundingAug 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?